MDMA has been gaining attention for its potential therapeutic applications. In recent years, MDMA therapy, particularly MDMA-assisted psychotherapy, has been a topic of extensive research, with MAPS’ …
The coming years could see a massive shift in the U.S. government’s approach to regulating hallucinogenic drugs. Several biopharma companies are developing psychedelics-based treatments for various mental …
Psychedelics and inequality are inseparable for Bronner, 49. Drug policy reform, he believes, is integral to criminal justice reform. His company has donated more than $25 million since 2015 toward drug …
The code was the result of a partnership between U.K.-based COMPASS Pathways and the Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation to facilitate access and insurance …
“Psychedelic-assisted therapies represent a potential new frontier in the treatment of mental health conditions, and our top priority is ensuring there is a path forward to integrate them into the health …
Summary: The article discusses the potential approval of MDMA for treating posttraumatic stress disorder (PTSD) in the United States based on positive results from clinical trials. If approved, this could …
Quote Originally appearing here (Archived)
“The majority of ketamine clinics do not provide adjunct psychotherapy,” claims Natalie Ginsberg, global impact officer at the Multidisciplinary Association for Psychedelic Studies (Maps), a research …
In 2017, MAPS-sponsored ibogaine researcher Thomas Kingsley Brown took it beyond mice and rats — he conducted his observational study on patients at the La Misión ibogaine clinic in Mexico. And Franciotti …
The bill – HD 2137, by state Rep. Nicholas Boldyga – was introduced in January, apparently in response to reporting by The Washington Post and The New York Times regarding moves by the nonprofit …
Becoming a psychedelic therapist requires vigorous training, psychedelic education, and extreme tenacity to grind through the uncertainty of the legality and creation of this career path. Originally appearing …
Andrew Huberman, PhD (@hubermanlab), is a neuroscientist and tenured professor in the Department of Neurobiology at Stanford University’s School of Medicine. He has made numerous important contributions …